Migraine clinical trials at UC Davis

2 in progress, 0 open to eligible people

Showing trials for

  • Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

    Sorry, not currently recruiting here

    The purpose of this study is to test the long-term safety of rimegepant in the acute treatment of migraine in children and adolescents (≥ 6 to < 18 years of age).

    Sacramento, California and other locations

  • Children and Adolescents With Migraine: Acute Treatment

    Sorry, not currently recruiting here

    The purpose of this study is to test the safety and efficacy of BHV-3000 versus placebo in the acute treatment of moderate or severe migraine in children and adolescents.

    Sacramento, California and other locations

Last updated: